Dr Rinki Murphy uses a case-based approach to diabetes management incorporating the new Diabetes Management Guidance and discusses where the newly funded dulaglutide fits.

In this episode, Rinki Murphy provides a practical guide to using Dulaglutide (Trulicity) for managing Type 2 Diabetes (T2D). We start with the importance of lifestyle interventions and weight reduction, then explore the role of pharmacological management and the science behind GLP-1 receptor agonists.

Dame Sue Bagshaw discusses teenage brain development and its influences - what this means for the GP - and how to optimise your communication to maximise your consult with the teenage patient.

Dr Nikki Turner discusses why people are vaccine hesitant and how we can help alleviate concerns and move patients from vaccine hesitant to fully immunised.

Dr Zuzana Wheeler discusses a case of anxiety and depression. She discusses how this case would be addressed using a lifestyle model (LSM). She overviews where you go to learn more and how to refer on to a LSM colleague.

Dr Matthew Phillips discusses metabolic strategies for the treatment of Alzheimer’s disease, including both fasting and the ketogenic diet. He also discusses results from his Waikato trials.

Simon Edmonds and Michael Wynn Williams discuss improving the diagnosis and management of endometriosis in New Zealand through early recognition of symptoms, empowering primary health care practitioners to make a suspected diagnosis and commence management along with appropriate and timely referral to specialists.

In this episode, Dr Cheryl Buhay will discuss Clozapine and primary care- what you need to know.

Clozapine is a second generation or atypical antipsychotic prescribed for treatment-resistant schizophrenia. It is usually commenced by secondary mental health services. Clozapine is associated with several side-effects and patients require close monitoring.

GP’s are responsible for caring for these patients and this podcast provides guidance on management and monitoring.

In this episode, Dr Cheryl Buhay will discuss Clozapine and primary care- what you need to know.

Clozapine is a second generation or atypical antipsychotic prescribed for treatment-resistant schizophrenia. It is usually commenced by secondary mental health services. Clozapine is associated with several side-effects and patients require close monitoring.

GP’s are responsible for caring for these patients and this podcast provides guidance on management and monitoring.

Dr Glen Davies is a passionate advocate of lifestyle approaches to reversing chronic disease. Through his prescription of LCHF/ keto diets, he has helped over 100 patients reverse their prediabetes and type 2 diabetes.